Quantum Biopharma (CVE:QNT – Get Free Report) was upgraded by stock analysts at Rodman & Renshaw to a “strong-buy” rating in a research note issued to investors on Monday, Zacks reports.
Quantum Biopharma Stock Performance
Quantum Biopharma Ltd. is a healthcare company in the Biotechnology industry.
Featured Articles
- Five stocks we like better than Quantum Biopharma
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Quantum Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
